{"authors": [["Blumental", "S", "S", "Unit\u00e9 de Maladies infectieuses p\u00e9diatriques, H.U.D.E.R.F., ULB."], ["Ferster", "A", "A", "Unit\u00e9 d'H\u00e9mato-Oncologie, H.U.D.E.R.F., ULB."], ["Azzi", "N", "N", "Unit\u00e9 d'H\u00e9mato-Oncologie, H.U.D.E.R.F., ULB."], ["Lepage", "P", "P", "Unit\u00e9 de Maladies infectieuses p\u00e9diatriques, H.U.D.E.R.F., ULB."]], "date": null, "id": "29178692", "text": "Over the last decades, significant advances in the diagnosis and therapeutics have considerably improved success rate from bone marrow transplant in patients suffering from otherwise life-threatening diseases, allowing now for prolonged survival and better quality of life after an allograft. However, infectious diseases remain one of the most serious complication in this population, hence associated with a high morbidity and mortality. Prevention, in particular through vaccination, constitutes a cornerstone of the management of immunocompromised hosts, since this procedure aims to protect them once back to life in community after long periods of hospitalization. If the necessity of vaccinating immunocompromised patients as well as their family is unequivocally recognized among health care workers, some questions remain source of debate. Several famous societies edited guidelines, but those differ from each other and cannot be transposed from a country to another without considering their local epidemiology and implemented vaccination schedule. Moreover, development and availability of new vaccines render recommendations constantly susceptible to adaptations. After exhaustive literature review, this article aims to offer pragmatic answers to the main questions raised by healthcare workers when vaccinating children after a bone marrow transplant. We here review all vaccines available and discuss their modalities of administration considering the timing after transplant, the immunological residual status and the medical history of the child. We also offer clues to optimize vaccination of patients' siblings. In addition to highlight some interrogations about future vaccines formulations, we propose here a vaccination schedule tailored for pediatric bone marrow transplant recipients in Belgium in 2017.Au cours des derni\u00e8res ann\u00e9es, les progr\u00e8s faits dans les domaines th\u00e9rapeutiques et diagnostiques ont permis d\u2019am\u00e9liorer les performances des traitements par greffes de moelle osseuse, allongeant ainsi significativement l\u2019esp\u00e9rance de vie des patients souffrant de maladies jusqu\u2019alors associ\u00e9es \u00e0 un sombre pronostic. Cependant, aujourd\u2019hui encore, les infections restent parmi les complications les plus redout\u00e9es en termes de morbidit\u00e9 et de mortalit\u00e9 chez ces patients. La pr\u00e9vention et particuli\u00e8rement la vaccination occupe donc une place primordiale dans la prise en charge de ces h\u00f4tes fragiles, visant \u00e0 les prot\u00e9ger une fois leur retour \u00e0 la vie en communaut\u00e9 envisag\u00e9 apr\u00e8s de longues p\u00e9riodes d\u2019immunosuppression. Si la n\u00e9cessit\u00e9 de vacciner les patients transplant\u00e9s et leur entourage fait l\u2019unanimit\u00e9 au sein des soignants, les modalit\u00e9s de vaccination restent encore sujettes \u00e0 de maintes interrogations dans la litt\u00e9rature. Plusieurs soci\u00e9t\u00e9s r\u00e9put\u00e9es font \u00e9tat de recommandations mais celles-ci varient entre elles et ne peuvent \u00eatre transpos\u00e9es d\u2019un pays \u00e0 l\u2019autre sans tenir compte de l\u2019\u00e9pid\u00e9miologie locale et du sch\u00e9ma vaccinal pr\u00e9alablement impl\u00e9ment\u00e9. Par ailleurs, la mise \u00e0 disposition constante de nouveaux vaccins n\u00e9cessite une adaptation perp\u00e9tuelle des diverses recommandations \u00e9tablies. Sur base d\u2019une revue exhaustive de la litt\u00e9rature, nous tenterons dans cet article d\u2019apporter des r\u00e9ponses pragmatiques aux questions fr\u00e9quemment soulev\u00e9es par les soignants en charge des enfants greff\u00e9s de moelle osseuse. Le document d\u00e9taille les diff\u00e9rents vaccins disponibles, en discute les crit\u00e8res d\u2019administration selon le d\u00e9lai par rapport \u00e0 la greffe et le statut immunologique du patient et revoit comment optimaliser la vaccination de l\u2019entourage. En plus de souligner certaines interrogations \u00e0 suivre concernant de nouvelles formulations vaccinales \u00e0 venir, l\u2019article ci-dessous offre un sch\u00e9ma pratique d\u2019administration des diff\u00e9rents vaccins chez les enfants receveurs d\u2019une greffe de moelle en Belgique en 2017.", "doi": null, "title": "[Management of vaccination in children receiving an allogeneic marrow transplant].", "journal": ["Revue medicale de Bruxelles", "Rev Med Brux"]}